Paper39508604
Both chebulagic acid and punicalagin inhibit respiratory syncytial virus entry via multi-targeting glycoprotein and fusion protein.
Xiong Y and 10 others. J Virol, 2024. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Both chebulagic acid and punicalagin inhibit respiratory syncytial virus entry via multi-targeting glycoprotein and fusion protein. Papers, record 39508604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39508604
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Both chebulagic acid and punicalagin inhibit respiratory syncytial virus entry via multi-targeting glycoprotein and fusion protein.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hydrolyzable Tannins | Major topic |
| Virus Internalization | Major topic |
| Antiviral Agents | Major topic |
| Viral Fusion Proteins | Major topic |
| Respiratory Syncytial Virus Infections | Major topic |
| Virus Replication | Major topic |
| Humans | |
| Animals | |
| Mice | |
| Glycoproteins | |
| Respiratory Syncytial Virus, Human | |
| Cell Line | |
| Heparan Sulfate Proteoglycans | |
| Benzopyrans | |
| Glucosides |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2023YFC2308200 | MOST | National Key Research and Development Program of China (NKPs) | PubMed | ||
| 82374524 | MOST | National Natural Science Foundation of China (NSFC) | PubMed | ||
| 2021-QNRC2-B14 | Young Elite scientists sponsorship Program by CACM | PubMed | ||
| 021093002906 | | Natural Science Research of Jiangsu Higher Education Institutions of China (Natural Science Foundation of Colleges and Universities in Jiangsu Province) | PubMed |
Source PubMed
References66
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29464672 | Assessing Variation in the Cost of Palivizumab for Respiratory Syncytial Virus Prevention in Preterm Infants. | Pharmacoecon Open | 2018 | https://conductscience.org/library/papers/29464672 | PubMed |
| 2 | 34125371 | Punicalagin ameliorates collagen-induced arthritis by downregulating M1 macrophage and pyroptosis via NF-κB signaling pathway. | Sci China Life Sci | 2022 | https://conductscience.org/library/papers/34125371 | PubMed |
| 3 | 38160942 | Current state and challenges in respiratory syncytial virus drug discovery and development. | Antiviral Res | 2024 | https://conductscience.org/library/papers/38160942 | PubMed |
| 4 | 30254193 | Small molecules targeting coxsackievirus A16 capsid inactivate viral particles and prevent viral binding. | Emerg Microbes Infect | 2018 | https://conductscience.org/library/papers/30254193 | PubMed |
| 5 | 38270052 | Resveratrol inhibits respiratory syncytial virus replication by targeting heparan sulfate proteoglycans. | Food Funct | 2024 | https://conductscience.org/library/papers/38270052 | PubMed |
| 6 | 26719246 | Identification of a Human Respiratory Syncytial Virus Cell Entry Inhibitor by Using a Novel Lentiviral Pseudotype System. | J Virol | 2015 | https://conductscience.org/library/papers/26719246 | PubMed |
| 7 | 36280532 | Development of mRNA vaccines against respiratory syncytial virus (RSV). | Cytokine Growth Factor Rev | 2022 | https://conductscience.org/library/papers/36280532 | PubMed |
| 8 | 1698933 | Anti-AIDS agents, 2: Inhibitory effects of tannins on HIV reverse transcriptase and HIV replication in H9 lymphocyte cells. | J Nat Prod | 1990 | https://conductscience.org/library/papers/1698933 | PubMed |
| 9 | 19723363 | The lack of protective immunity against RSV in the elderly. | Epidemiol Infect | 2009 | https://conductscience.org/library/papers/19723363 | PubMed |
| 10 | 37098418 | Edible alginate-based films with anti-SARS-CoV-2 activity. | Food Microbiol | 2023 | https://conductscience.org/library/papers/37098418 | PubMed |
| 11 | 22194690 | The membrane fusion step of vaccinia virus entry is cooperatively mediated by multiple viral proteins and host cell components. | PLoS Pathog | 2011 | https://conductscience.org/library/papers/22194690 | PubMed |
| 12 | 34296672 | Low levels of respiratory syncytial virus activity in Europe during the 2020/21 season: what can we expect in the coming summer and autumn/winter? | Euro Surveill | 2021 | https://conductscience.org/library/papers/34296672 | PubMed |
| 13 | 25558771 | Surface plasmon resonance (SPR) biosensors in pharmaceutical analysis. | Crit Rev Anal Chem | 2015 | https://conductscience.org/library/papers/25558771 | PubMed |
| 14 | 26658574 | Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures. | PLoS Pathog | 2015 | https://conductscience.org/library/papers/26658574 | PubMed |
| 15 | 28469033 | A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants. | Sci Transl Med | 2017 | https://conductscience.org/library/papers/28469033 | PubMed |
| 16 | 24812523 | Respiratory syncytial virus: current and emerging treatment options. | Clinicoecon Outcomes Res | 2014 | https://conductscience.org/library/papers/24812523 | PubMed |
| 17 | 29510663 | Burden of severe RSV disease among immunocompromised children and adults: a 10 year retrospective study. | BMC Infect Dis | 2018 | https://conductscience.org/library/papers/29510663 | PubMed |
| 18 | 28761099 | Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor. | Nat Commun | 2017 | https://conductscience.org/library/papers/28761099 | PubMed |
| 19 | 36463892 | Decline of RSV-specific antibodies during the COVID-19 pandemic. | Lancet Infect Dis | 2023 | https://conductscience.org/library/papers/36463892 | PubMed |
| 20 | 21208913 | Analysis of respiratory syncytial virus preclinical and clinical variants resistant to neutralization by monoclonal antibodies palivizumab and/or motavizumab. | J Infect Dis | 2011 | https://conductscience.org/library/papers/21208913 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42790425 | Punicalin targets RSV glycoprotein and fusion protein at non-overlapping sites to prevent viral escape. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/42790425 | PubMed |
| 41459485 | Multimodal cell death drives the immunopathogenesis of RSV infection. | Front Immunol | 2025 | https://conductscience.org/library/papers/41459485 | PubMed |
| 41236925 | Protoporphyrin IX targets viral spike glycoproteins to inactivate Akabane virus. | Virulence | 2025 | https://conductscience.org/library/papers/41236925 | PubMed |
| 41230964 | New insight into the epidemiological trends of respiratory syncytial virus infection and the underlying anti-respiratory syncytial virus mechanisms of andrographolide: integrating Global Burden of Disease database, network pharmacological analysis, and in vitro experiments. | Microbiol Spectr | 2026 | https://conductscience.org/library/papers/41230964 | PubMed |
| 41142773 | Virus infection and vesicle trafficking. | Front Immunol | 2025 | https://conductscience.org/library/papers/41142773 | PubMed |
| 40569507 | Potential use of plant secondary metabolites in the treatment of allergic respiratory diseases (ARDs). | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/40569507 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SDC2 | 6383 | PubTator's text mining | https://conductscience.org/library/genes/6383 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39508604
GET https://conductscience.org/api/papers/v1/39508604/references?page=2